{"id":"W2298315650","doi":"10.1016/j.eururo.2016.03.017","title":"The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Placebo; Hazard ratio; Internal medicine; Androgen deprivation therapy; Oncology; Clinical endpoint; Gastroenterology; Urology; Cancer; Surgery; Confidence interval; Randomized controlled trial; Pathology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001003065,0.0009736574,0.00147609,0.0006534882,0.0004529316,0.001048289,0.0006002122,0.0008211887,0.001867824],"category_scores_gemma":[0.0009842513,0.0004789259,0.002179181,0.0009326036,0.0005238873,0.0008983219,0.0009319089,0.001120438,0.0002483286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006412101,"about_ca_system_score_gemma":0.0007785677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005678119,"about_ca_topic_score_gemma":0.01590835,"domain_scores_codex":[0.9994268,0.0002250315,0.00003608496,0.0001388194,0.00007740896,0.00009576478],"domain_scores_gemma":[0.9993499,0.000129765,0.0002331433,0.00005190752,0.0000451492,0.0001901726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1164278,0.001874562,0.8559974,0.0006352114,0.007469257,0.0003219588,0.0002746856,0.0005584154,0.002640374,0.0001689701,0.001740894,0.0118905],"study_design_scores_gemma":[0.008105642,0.008156106,0.9768175,0.00005970988,0.003718448,0.000315077,0.0003723744,0.0004035385,0.0004631365,0.0001572834,0.001381659,0.0000494723],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957567,0.001247856,0.00008578425,0.00009534979,0.00002659825,0.00008187277,0.002080929,0.000008168212,0.0006167666],"genre_scores_gemma":[0.992361,0.0006431072,0.0002251949,0.0002231818,0.0001205263,0.0001063763,0.005394894,0.00001188035,0.000913701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005678119,"threshold_uncertainty_score":0.01129013,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01654673967884315,"score_gpt":0.29596243410123,"score_spread":0.2794156944223869,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}